Immunotherapy drug improves survival of patients with squamous non–small cell lung cancer

E-ISSN： 1097-0142|121|20|3562-3563

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.20, 2015-10, pp. : 3562-3563

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cryoablation Combined with Molecular Target Therapy Improves the Curative Effect in Patients with Advanced Non-small Cell Lung Cancer

By Gu XY Jiang Z Fang W

The Journal of International Medical Research, Vol. 39, Iss. 5, 2011-09 ,pp. : 1736-1743

Field House Publishing

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients

By Leon Luis Vázquez Sergio Gracia José Manuel Casal Joaquín Lazaro Martín Firvida José Luis Amenedo Margarita Santome Lucia Macia Sonia

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1389-1396

Informa Healthcare

Access to resources Recommend Favorite

Quality of Life and Utility in Patients with Non-Small Cell Lung Cancer

By Trippoli S. Vaiani M. Lucioni C. Messori A.

PharmacoEconomics, Vol. 19, Iss. 8, 2001-01 ,pp. : 855-863

Adis International

Access to resources Recommend Favorite

The role of gefitinib in the management of Asian patients with non-small cell lung cancer

By Chang Alex Y

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 401-411

Informa Healthcare

Access to resources Recommend Favorite